KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Short-Term Debt issuances (2016 - 2017)

Bio-Rad Laboratories (BIO) has disclosed Short-Term Debt issuances for 6 consecutive years, with -$36000.0 as the latest value for Q1 2017.

  • On a quarterly basis, Short-Term Debt issuances changed N/A to -$36000.0 in Q1 2017 year-over-year; TTM through Dec 2017 was -$36000.0, a 197.3% decrease, with the full-year FY2017 number at -$36000.0, down 197.3% from a year prior.
  • Short-Term Debt issuances was -$36000.0 for Q1 2017 at Bio-Rad Laboratories, down from $37000.0 in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $74000.0 in Q3 2015 to a low of -$1.2 million in Q4 2014.
  • A 5-year average of -$137363.6 and a median of -$19000.0 in 2013 define the central range for Short-Term Debt issuances.
  • Peak YoY movement for Short-Term Debt issuances: skyrocketed 200.0% in 2013, then tumbled 1915.15% in 2014.
  • Bio-Rad Laboratories' Short-Term Debt issuances stood at $66000.0 in 2013, then crashed by 1915.15% to -$1.2 million in 2014, then skyrocketed by 93.82% to -$74000.0 in 2015, then soared by 150.0% to $37000.0 in 2016, then plummeted by 197.3% to -$36000.0 in 2017.
  • Per Business Quant, the three most recent readings for BIO's Short-Term Debt issuances are -$36000.0 (Q1 2017), $37000.0 (Q4 2016), and -$74000.0 (Q4 2015).